Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial
Go back to Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial| (NASDAQ: GLSI) | Delayed: 18.33 -3.19 (14.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.52 | 52 Week High | $ | |||
| Open | $21.80 | 52 Week Low | $ | |||
| Day High | $22.32 | P/E | N/A | |||
| Day Low | $16.52 | EPS | $ | |||
| Volume | 444,052 | |||||

